For academia and industry, MTAs are the means to widely differing ends.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barton J.H. & Siebeck W.E. Material transfer agreements in genetic resources exchange: the case of the international agricultural research centers. Issues in Genetic Resources No. 1 (International Plant Genetic Resources Institute, Rome, 1994).
Streitz W.D. et al. Material transfer agreements: a win-win for academia and industry. Annual meeting of the AUTM (AUTM, Northbrook, 2003).
Council of Governmental Relations. Material Transfer in Academia (COGR, Washington, 1997).
Whitaker, J.S. The prior art effect of material transfer agreements. J. Assoc. Univ. Technol. Managers VI, 1–10 (1994).
Acknowledgements
The author would like to thank Jean Gilbert for helpful comments on drafts of this article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodriguez, V. Material transfer agreements: open science vs. proprietary claims. Nat Biotechnol 23, 489–491 (2005). https://doi.org/10.1038/nbt0405-489
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0405-489
This article is cited by
-
Stem‐cell tourism and scientific responsibility
EMBO reports (2011)
-
Reply to Conflating MTAs and patents
Nature Biotechnology (2009)
-
Livin’ with the MTA
Minerva (2008)
-
Do material transfer agreements affect the choice of research agendas? The case of biotechnology in Belgium
Scientometrics (2007)
-
Proliferating Patent Problems with Human Embryonic Stem Cell Research?
Journal of Bioethical Inquiry (2006)
